Ceres Pharmaceuticals SA
17.6 FTEThe score of Ceres Pharmaceuticals shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +34 % Equity -57 % Total assets +104 % Headcount (avg FTE) -25 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Ceres Pharmaceuticals's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €14.6m | ||||
| Net result | €2.64m | ||||
| Equity | €1.32m | ||||
| Cash | 39,350 € | ||||
| EBITDA | €3.53m | ||||
| Total assets | €9.46m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jul 2026
- Year ended 31 Dec 2024filed on 30 Jul 2025
- Year ended 31 Dec 2023filed on 03 Jul 2024
- Year ended 31 Dec 2022filed on 18 Jul 2023
- Year ended 31 Dec 2021filed on 20 Jul 2022
Ceres Pharmaceuticals's financial analysis
- Solvency13.9%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Ceres Pharmaceuticals
Ceres Pharmaceuticals's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0407.326.754
- VAT number
- BE0407326754
- Peppol
- Registered · 0208:0407326754 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 23 Sep 1970
- Registered office
- 9051 Ghent
- Size
- Small · 17.6 FTE
- Latest accounts
- 2025 · filed on 22 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Ceres Pharmaceuticals (SA) has been based in Ghent since 1970, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €14.6m, a net profit of €2.64m and equity of €1.32m. With 17.6 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 13.9%, below the median of its sector (46.0%).
Companies similar to Ceres Pharmaceuticals
Companies in the same business, of comparable size and area, outside its group.
- PHOENIX Pharma Belgium Manufacture of pharmaceutical preparations Woluwe-Saint-Lambert · balance sheet €235.4m
- Bausch & Lomb Pharma Wholesale of pharmaceutical and medical goods Wavre · balance sheet €9.17m
- S.A Therabel-Pharma N.V. Wholesale of pharmaceutical and medical goods Forest · balance sheet €12.8m
- Almirall Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €7.75m
- Elekta Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €13.1m
- Norgine Wholesale of pharmaceutical and medical goods Leuven · balance sheet €14.1m
- Leo Pharma Wholesale of pharmaceutical and medical goods Lier · balance sheet €15.1m
- Biogen Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €25.5m
Frequently asked questions about Ceres Pharmaceuticals
What is the revenue of Ceres Pharmaceuticals?
According to the 2025 annual accounts filed with the NBB, the revenue of Ceres Pharmaceuticals amounts to 14,578,548 €.
What is the VAT number of Ceres Pharmaceuticals?
In Belgium, the VAT number is the company number prefixed with BE: BE0407326754 for Ceres Pharmaceuticals, if the company is VAT-registered. Its company number (CBE) is 0407.326.754.
Where is the registered office of Ceres Pharmaceuticals?
According to the CBE register, the registered office of Ceres Pharmaceuticals is in 9051 Ghent.
What is the equity of Ceres Pharmaceuticals?
At the close of the 2025 financial year, the equity of Ceres Pharmaceuticals amounts to 1,318,968 €, a solvency of 13.9% of total assets.
How many people work at Ceres Pharmaceuticals?
17.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Ceres Pharmaceuticals?
The register lists 4 active mandates at Ceres Pharmaceuticals. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Ceres Pharmaceuticals
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →